coin криптовалюта- Top searches

Zhejiang has published a list of the top 500 enterprises. According to the news released by Zhejiang in WeChat official account, Zhejiang Institute of Science and Technology Information organized the evaluation of innovation ability of high-tech enterprises, and recently selected the top 500 high-tech enterprises in Zhejiang Province in 2024. Among them, Hangzhou Hikvision Digital Technology Co., Ltd., Ningbo Oaks Electric Co., Ltd. and Xinhua San Technology Co., Ltd. are in the top three.Nearly 40% of the skilled talents in Shenzhen exceed 4 million, and the total number of skilled talents in Shenzhen now reaches 4.033 million, and the proportion of skilled talents has increased to 38.5%. The team size and the proportion of skilled talents are among the highest in the country ... From the launching ceremony of the 4th Shenzhen Craftsman Week and the summary meeting of skilled talents in 2024 held recently, it was learned that the construction of high-skilled talents in Shenzhen achieved positive results in 2024, which became an important foundation for supporting Shenzhen's manufacturing and Shenzhen's innovation. (Shenzhen Special Zone Daily)The turnover of Shanghai and Shenzhen stock markets exceeded 1 trillion for the 52nd consecutive trading day, exceeding 10 billion compared with yesterday.

In the concept of ice and snow economy, there were many daily limit changes, such as iceberg cold and hot, iceberg cold and hot, Longjian shares and Jingxue energy-saving daily limit, and Dalian Shengya, Changbai Mountain, Yeti shares and Sante ropeway were among the top gainers.Meitu, a Hong Kong stock company, rose more than 10% in intraday trading, with turnover exceeding HK$ 400 million.According to sources, Hamas's demand for a ceasefire in the Israeli Gaza has been relaxed, and a hostage agreement is expected to be reached. According to sources, Hamas will now agree to let the Israeli army stay temporarily after the fighting stops.

Xiong 'an Center of Beijing-Tianjin-Hebei National Technology Innovation Center officially started operation. On December 12th, Xiong 'an Center of Beijing-Tianjin-Hebei National Technology Innovation Center officially started operation, including the cooperation project of Xiong 'an Medical and Industrial Cross Transformation Research Institute of Peking University People's Hospital and the fourth generation semiconductor material doped AlN epitaxial wafer, and many independent innovative projects landed in xiong'an new area. As a national innovation platform, Xiong 'an Center will focus on key tasks such as building a first-class innovation platform, forming a composite innovation team, and improving the innovation and entrepreneurship ecology, and strive to create an important source of independent innovation and original innovation. (CCTV News)The trading of traditional Chinese medicine has increased the daily limit of Panlong Pharmaceutical, the trading of traditional Chinese medicine has increased, Panlong Pharmaceutical has increased its daily limit, Xiangxue Pharmaceutical has increased by over 9%, and Kunyao Group, Weikang Pharmaceutical, Huasen Pharmaceutical and Xinguang Pharmaceutical have followed suit.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.